High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment

Journal of Clinical Oncology

Volumn 18, Issue 15, 2000, Pages 2843-2851

  Davies, Faith E ^a   Rollinson, Sara J ^a   Rawstron, Andrew C ^a   Roman, Eve ^a   Richards, Stephen ^a   Drayson, Mark ^a   Child, Anthony J ^a   Morgan, Gareth J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CARMUSTINE; CREATININE; CYCLOPHOSPHAMIDE; DNA; DOXORUBICIN; HEMOGLOBIN; IMMUNOGLOBULIN; LYMPHOTOXIN; MELPHALAN; METHYLPREDNISOLONE; RECOMBINANT ALPHA2A INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033868516     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.15.2843     Document Type: Article

References (32)

1. Case-control study for multiple myeloma and farming
2. Infectious and noninfectious exposures in the etiology of light chain myeloma: A case-control study
3. Allergies and agricultural exposure as risk factors for multiple myeloma
4. Multiple myeloma: A case-control study
5. Antigenic stimulation and the occurrence of multiple myeloma
6. Leukemia, lymphoma and multiple myeloma following selected medical conditions
7. Experimental models of Ig-secreting tumors
8. Tumor necrosis factor ligand superfamily involvement in the pathology of malignant lymphomas
9. Distinct roles for lymphotoxin alpha and tumour necrosis factor alpha in organogenesis and spatial organisation of lymphoid tissue
10. Lymphotoxin-alpha-deficient and TNF-receptor-I deficient mice define developmental and functional characteristics of germinal centers
11. Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice
12. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma
13. The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma
14. Tumour necrosis factor-alpha and interleukin 4 in myeloma cell precursor differentiation
15. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product
16. Genetic variation at the human necrosis factor loci
17. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles
18. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
19. Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production
20. Variation in the TNF alpha promoter region associated with susceptibility to cerebral malaria
21. Heritable major histo-compatibility complex class II-associated differences in production of tumor necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosus
22. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
23. Polymorphic variation within the glutathione s-transferase genes and risk of adult leukaemia
24. Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis: The Medical Research Council Working Party for Leukaemia in Adults
25. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation: Myeloma Subcommittee of the EBMT - European Group for Blood and Marrow Transplant
26. Tissue extraction of DNA and RNA analysis by the polymerase chain reaction
27. Monclonal gammopathy of undetermined significance and solitary plasmacytoma: Implications for progression to overt multiple myeloma
28. Multiple myeloma and family history of cancer among blacks and whites in the U.S
29. Multiple myeloma among blacks and whites in the United States: The role of chronic antigenic stimulation
30. Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients
31. Polymorphisms of the tumour necrosis factor-alpha and lymphotoxin alpha genes in chronic lymphocytic leukaemia
32. Polymorphisms of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in hairy cell leukaemia